ATC code - L01FD01
Ukraine-
Form: lyophilisate for concentrate for infusion solution
Active substance Dosage trastuzumab 150 mg ATC code: L01FD01
Manufacturer: Genentech Inc. (Manufacturing of unpackaged products, primary packaging)
-
Form: lyophilisate for concentrate for infusion solution
Active substance Dosage trastuzumab 440 mg ATC code: L01FD01
-
Form: solution for injection
Active substance Dosage trastuzumab 600 mg/5 ml ATC code: L01FD01
Manufacturer: F. Hoffmann-La Roche Ltd (manufacturing unpackaged products, packaging, quality control testing, batch release)
-
Form: lyophilisate for concentrate for infusion solution
Active substance Dosage trastuzumab 150 mg ATC code: L01FD01
Manufacturer: PJSC Pharmaceutical Plant Egis (quality control, secondary packaging)
-
Form: lyophilisate for concentrate for infusion solution
Active substance Dosage trastuzumab 440 mg ATC code: L01FD01
Manufacturer: PJSC Pharmaceutical Plant Egis (medicinal product: quality control, secondary packaging)
-
Form: powder for concentrate for infusion solution
Active substance Dosage trastuzumab 150 mg ATC code: L01FD01
Manufacturer: Patheon Italia S.p.A. (manufacturing, primary packaging, quality control testing (sterility))
-
Form: powder for concentrate for infusion solution
Active substance Dosage trastuzumab 420 mg ATC code: L01FD01
Manufacturer: Fareva Paull (Manufacturing, primary packaging; quality control testing (bacterial endotoxins and sterility))
-
Form: powder for concentrate for infusion solution
Active substance Dosage trastuzumab 150 mg ATC code: L01FD01
Manufacturer: Accord Healthcare Polska Sp. z o.o. Importer's Warehouse (Responsible for batch release)